Quantitative Investment Management, LLC Innoviva, Inc. Transaction History

Quantitative Investment Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$10.05 - $14.55 $111,575 - $161,534	-11,102 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$13.1 - $14.95 $140,143 - $159,935	-10,698 Reduced 49.07%	11,102 $161,000
Q1 2019 May 15, 2019	SELL	$13.69 - $20.06 $41,070 - $60,179	-3,000 Reduced 12.1%	21,800 $305,000
Q4 2018 Feb 12, 2019	BUY	$13.96 - $18.26 $346,208 - $452,848	24,800 New	24,800 $432,000
Q2 2018 Aug 10, 2018	SELL	$13.44 - $17.59 $861,504 - $1.13 Million	-64,100 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$13.8 - $16.99 $884,580 - $1.09 Million	64,100 New	64,100 $1.07 Million
Q4 2017 Feb 14, 2018	SELL	$11.73 - $14.75 $832,830 - $1.05 Million	-71,000 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$12.06 - $14.12 $856,260 - $1 Million	71,000	71,000 $1 Million

229

79.2M

37.6K

300

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.33B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

Get notified when there are updates to the investment portfolio of Quantitative Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Quantitative Investment Management, LLC with notifications on news.